Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immunohistochemistry
1.2.3 Molecular Diagnosis
1.3 Market by Application
1.3.1 Global Companion Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Virology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostic Market Perspective (2017-2028)
2.2 Companion Diagnostic Growth Trends by Region
2.2.1 Companion Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Companion Diagnostic Historic Market Size by Region (2017-2022)
2.2.3 Companion Diagnostic Forecasted Market Size by Region (2023-2028)
2.3 Companion Diagnostic Market Dynamics
2.3.1 Companion Diagnostic Industry Trends
2.3.2 Companion Diagnostic Market Drivers
2.3.3 Companion Diagnostic Market Challenges
2.3.4 Companion Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Players by Revenue
3.1.1 Global Top Companion Diagnostic Players by Revenue (2017-2022)
3.1.2 Global Companion Diagnostic Revenue Market Share by Players (2017-2022)
3.2 Global Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Revenue
3.4 Global Companion Diagnostic Market Concentration Ratio
3.4.1 Global Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Revenue in 2021
3.5 Companion Diagnostic Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Breakdown Data by Type
4.1 Global Companion Diagnostic Historic Market Size by Type (2017-2022)
4.2 Global Companion Diagnostic Forecasted Market Size by Type (2023-2028)
5 Companion Diagnostic Breakdown Data by Application
5.1 Global Companion Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Companion Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Companion Diagnostic Market Size (2017-2028)
6.2 North America Companion Diagnostic Market Size by Type
6.2.1 North America Companion Diagnostic Market Size by Type (2017-2022)
6.2.2 North America Companion Diagnostic Market Size by Type (2023-2028)
6.2.3 North America Companion Diagnostic Market Share by Type (2017-2028)
6.3 North America Companion Diagnostic Market Size by Application
6.3.1 North America Companion Diagnostic Market Size by Application (2017-2022)
6.3.2 North America Companion Diagnostic Market Size by Application (2023-2028)
6.3.3 North America Companion Diagnostic Market Share by Application (2017-2028)
6.4 North America Companion Diagnostic Market Size by Country
6.4.1 North America Companion Diagnostic Market Size by Country (2017-2022)
6.4.2 North America Companion Diagnostic Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Companion Diagnostic Market Size (2017-2028)
7.2 Europe Companion Diagnostic Market Size by Type
7.2.1 Europe Companion Diagnostic Market Size by Type (2017-2022)
7.2.2 Europe Companion Diagnostic Market Size by Type (2023-2028)
7.2.3 Europe Companion Diagnostic Market Share by Type (2017-2028)
7.3 Europe Companion Diagnostic Market Size by Application
7.3.1 Europe Companion Diagnostic Market Size by Application (2017-2022)
7.3.2 Europe Companion Diagnostic Market Size by Application (2023-2028)
7.3.3 Europe Companion Diagnostic Market Share by Application (2017-2028)
7.4 Europe Companion Diagnostic Market Size by Country
7.4.1 Europe Companion Diagnostic Market Size by Country (2017-2022)
7.4.2 Europe Companion Diagnostic Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Market Size (2017-2028)
8.2 Asia-Pacific Companion Diagnostic Market Size by Type
8.2.1 Asia-Pacific Companion Diagnostic Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Companion Diagnostic Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Companion Diagnostic Market Share by Type (2017-2028)
8.3 Asia-Pacific Companion Diagnostic Market Size by Application
8.3.1 Asia-Pacific Companion Diagnostic Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Companion Diagnostic Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Companion Diagnostic Market Share by Application (2017-2028)
8.4 Asia-Pacific Companion Diagnostic Market Size by Region
8.4.1 Asia-Pacific Companion Diagnostic Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Companion Diagnostic Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Companion Diagnostic Market Size (2017-2028)
9.2 Latin America Companion Diagnostic Market Size by Type
9.2.1 Latin America Companion Diagnostic Market Size by Type (2017-2022)
9.2.2 Latin America Companion Diagnostic Market Size by Type (2023-2028)
9.2.3 Latin America Companion Diagnostic Market Share by Type (2017-2028)
9.3 Latin America Companion Diagnostic Market Size by Application
9.3.1 Latin America Companion Diagnostic Market Size by Application (2017-2022)
9.3.2 Latin America Companion Diagnostic Market Size by Application (2023-2028)
9.3.3 Latin America Companion Diagnostic Market Share by Application (2017-2028)
9.4 Latin America Companion Diagnostic Market Size by Country
9.4.1 Latin America Companion Diagnostic Market Size by Country (2017-2022)
9.4.2 Latin America Companion Diagnostic Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Market Size (2017-2028)
10.2 Middle East & Africa Companion Diagnostic Market Size by Type
10.2.1 Middle East & Africa Companion Diagnostic Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Companion Diagnostic Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Companion Diagnostic Market Share by Type (2017-2028)
10.3 Middle East & Africa Companion Diagnostic Market Size by Application
10.3.1 Middle East & Africa Companion Diagnostic Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Companion Diagnostic Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Companion Diagnostic Market Share by Application (2017-2028)
10.4 Middle East & Africa Companion Diagnostic Market Size by Country
10.4.1 Middle East & Africa Companion Diagnostic Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Companion Diagnostic Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche Holdings
11.1.1 Roche Holdings Company Details
11.1.2 Roche Holdings Business Overview
11.1.3 Roche Holdings Companion Diagnostic Introduction
11.1.4 Roche Holdings Revenue in Companion Diagnostic Business (2017-2022)
11.1.5 Roche Holdings Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Companion Diagnostic Introduction
11.2.4 Abbott Laboratories Revenue in Companion Diagnostic Business (2017-2022)
11.2.5 Abbott Laboratories Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Companion Diagnostic Introduction
11.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2017-2022)
11.3.5 Thermo Fisher Scientific Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Companion Diagnostic Introduction
11.4.4 Agilent Technologies Revenue in Companion Diagnostic Business (2017-2022)
11.4.5 Agilent Technologies Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Companion Diagnostic Introduction
11.5.4 Merck Revenue in Companion Diagnostic Business (2017-2022)
11.5.5 Merck Recent Developments
11.6 Agendia
11.6.1 Agendia Company Details
11.6.2 Agendia Business Overview
11.6.3 Agendia Companion Diagnostic Introduction
11.6.4 Agendia Revenue in Companion Diagnostic Business (2017-2022)
11.6.5 Agendia Recent Developments
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Companion Diagnostic Introduction
11.7.4 Qiagen Revenue in Companion Diagnostic Business (2017-2022)
11.7.5 Qiagen Recent Developments
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Details
11.8.2 Myriad Genetics Business Overview
11.8.3 Myriad Genetics Companion Diagnostic Introduction
11.8.4 Myriad Genetics Revenue in Companion Diagnostic Business (2017-2022)
11.8.5 Myriad Genetics Recent Developments
11.9 Advanced Cell Diagnostics
11.9.1 Advanced Cell Diagnostics Company Details
11.9.2 Advanced Cell Diagnostics Business Overview
11.9.3 Advanced Cell Diagnostics Companion Diagnostic Introduction
11.9.4 Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2017-2022)
11.9.5 Advanced Cell Diagnostics Recent Developments
11.10 Danaher
11.10.1 Danaher Company Details
11.10.2 Danaher Business Overview
11.10.3 Danaher Companion Diagnostic Introduction
11.10.4 Danaher Revenue in Companion Diagnostic Business (2017-2022)
11.10.5 Danaher Recent Developments
11.11 Illumina, Inc
11.11.1 Illumina, Inc Company Details
11.11.2 Illumina, Inc Business Overview
11.11.3 Illumina, Inc Companion Diagnostic Introduction
11.11.4 Illumina, Inc Revenue in Companion Diagnostic Business (2017-2022)
11.11.5 Illumina, Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer